10000|10000|Public
25|$|Genetic {{sequences}} {{are often}} sampled at multiple <b>time</b> <b>points,</b> {{which allows the}} estimation of substitution rates {{and the time of}} the MRCA using a molecular clock model.|$|E
25|$|Mutation rate {{of human}} genome {{is a very}} {{important}} factor in calculating evolutionary <b>time</b> <b>points.</b> Researchers calculated the number of genetic variations between human and apes. Dividing that number by age of fossil of most recent common ancestor of humans and ape, researchers calculated the mutation rate. Recent studies using next generation sequencing technologies concluded a slow mutation rate which doesn't add up with human migration pattern <b>time</b> <b>points</b> and suggesting a new evolutionary time scale. 100,000 year old human fossils found in Israel have served to compound this new found uncertainty of the human migration timeline.|$|E
25|$|Nociceptive {{threshold}} testing deliberately applies a noxious {{stimulus to}} a human or animal subject in order to study pain. In animals, the technique {{is often used to}} study the efficacy of analgesic drugs and to establish dosing levels and period of effect. After establishing a baseline, the drug under test is given and the elevation in threshold recorded at specified <b>time</b> <b>points.</b> When the drug wears off, the threshold should return to the baseline (pre-treatment) value.|$|E
30|$|<b>Time</b> <b>point</b> a and <b>time</b> <b>point</b> b is discontinuous.|$|R
3000|$|... [...])] are {{activated}} at <b>time</b> <b>point</b> 2 and, more importantly, {{with the}} same rate of activation strength until <b>time</b> <b>point</b> 15 (this highlights the non-biased effects in early action formation). Nevertheless, after <b>time</b> <b>point</b> 15, {{it is clear that}} option a [...]...|$|R
40|$|We {{present a}} brief {{overview}} of targeted maximum likelihood for estimating the causal effect of a single <b>time</b> <b>point</b> treatment and of a two <b>time</b> <b>point</b> treatment. We focus on simple examples demonstrating how to apply the methodology developed in (van der Laan and Rubin, 2006; Moore and van der Laan, 2007; van der Laan, 2010 a,b). We include R code for the single <b>time</b> <b>point</b> case...|$|R
25|$|Measuring the {{expression}} of an organism’s genes in different tissues, conditions, or <b>time</b> <b>points</b> gives information on how genes are regulated and reveal details of an organism’s biology. It can also help to infer the functions of previously unannotated genes. Transcriptomic analysis has enabled the study of how gene expression changes in different organisms and {{has been instrumental in}} the understanding of human disease. An analysis of gene expression in its entirety allows detection of broad coordinated trends which cannot be discerned by more targeted assays.|$|E
25|$|A double-blind, randomized, {{placebo-controlled}} 28-week {{study examined}} the effect of Juice Plus (two capsules each of Orchard Blend, Garden Blend, and Vineyard blend per day) on cytokine (i.e., IL-6 and TNF-α) levels, and on the incidence of illness. Subjects who took Juice Plus had lower TNF-α levels than the placebo group at later <b>time</b> <b>points</b> in the study (week 16 and 28) but overall the effect was not statistically significant. Juice Plus {{was found to have}} no significant effect on IL-6 levels or on the incidence of illness {{during the course of the}} study.|$|E
25|$|Portimão is {{the host}} venue for many prestigious sailing events {{including}} the annual Portimão, Portugal Match Cup event which {{is a part of}} the World Match Racing Tour. The event draws the world's best sailing teams to Portimão. The identical supplied (SM-40) boats are raced two at a <b>time.</b> <b>Points</b> accrued count towards the World Match Race Tour and a place in the final event of the season, with the overall winner taking the title ISAF World Match Racing Tour Champion. Match racing is an ideal sport for spectators in Portimão.|$|E
30|$|MDR - No alarm is {{triggered}} at a <b>time</b> <b>point</b> {{where an}} example of a confirmed anomalous event exists in at least one <b>time</b> <b>point</b> in the next d time steps (Martin et al. 2015).|$|R
30|$|It refers {{that the}} point that current deficit {{secondly}} appears. In various situations, the <b>time</b> <b>point</b> that pension fund deficit appears is {{in the year of}} 2023, but the second <b>time</b> <b>point</b> that deficit appears is different.|$|R
30|$|FAR - An alarm is {{triggered}} at a <b>time</b> <b>point</b> {{that does}} not contain {{an example of a}} confirmed anomalous event in at least one <b>time</b> <b>point</b> in the next d time steps (Martin et al. 2015).|$|R
25|$|Hybridization capture {{with the}} {{selector}} probe set is performed on tumor DNA from a biopsy and sequenced {{to a depth}} of ~10,000× coverage. The biotinylated selector probes bind selectively to the regions of the DNA library that were chosen to be where the recurrently mutations occur in the given cancer type. In this way you are left with a smaller library that is enriched for only the regions you want, which can then be sequenced. This allows the determination of patient specific mutations. Hybridization capture with the same selector is then performed on ctDNA from the blood to quantify the previously identified mutations in the patient. CAPP-Seq can be applied to ctDNA from multiple blood samples at different <b>time</b> <b>points</b> in order to follow tumor evolution.|$|E
25|$|Of the 12 populations, six have so {{far been}} {{reported}} to have developed defects {{in their ability to}} repair DNA, greatly increasing the rate of mutation in those strains. Although the bacteria in each population are thought to have generated hundreds of millions of mutations over the first 20,000 generations, Lenski has estimated that within this time frame, only 10 to 20 beneficial mutations achieved fixation in each population, with fewer than 100 total point mutations (including neutral mutations) reaching fixation in each population. In 2009, Barrick et al. reported the results of genome sequences from multiple <b>time</b> <b>points</b> in population Ara-1. They found that, unlike the declining rate of fitness improvement, mutation accumulation was linear and clock like, even though several lines of evidence suggested that much of the accumulation was beneficial, rather than neutral.|$|E
25|$|Pharmacokinetics {{is often}} studied using mass {{spectrometry}} {{because of the}} complex nature of the matrix (often blood or urine) {{and the need for}} high sensitivity to observe low dose and long time point data. The most common instrumentation used in this application is LC-MS with a triple quadrupole mass spectrometer. Tandem mass spectrometry is usually employed for added specificity. Standard curves and internal standards are used for quantitation of usually a single pharmaceutical in the samples. The samples represent different <b>time</b> <b>points</b> as a pharmaceutical is administered and then metabolized or cleared from the body. Blank or t=0 samples taken before administration are important in determining background and ensuring data integrity with such complex sample matrices. Much attention is paid to the linearity of the standard curve; however {{it is not uncommon to}} use curve fitting with more complex functions such as quadratics since the response of most mass spectrometers is less than linear across large concentration ranges.|$|E
40|$|ObjectiveProlonged venoarterial extracorporeal {{membrane}} oxygenation support during transplantation provides {{reduction of}} pulmonary artery flow {{and allows for}} protective ventilation. This approach might have the potential to restore function of lungs that would be unsuitable for transplantation. MethodsLeft lung transplantation was performed on 16 pigs. Lungs from brain-dead animals were stored for 22 hours at 4 °C. Recipients in group A (n = 8) underwent transplantation without cardiopulmonary support followed by ventilation with 10 mL/kg body weight tidal volume. Animals in group B (n = 8) underwent transplantation during {{venoarterial extracorporeal membrane oxygenation}}, which was continued for 22 hours, and received low-tidal-volume (5 mL/kg body weight) ventilation. One hour after transplantation, the right lung was excluded. Graft function was compared immediately after exclusion of the contralateral lung (<b>time</b> <b>point</b> 1), 1 hour later (<b>time</b> <b>point</b> 2), and 1 hour after discontinuation of extracorporeal membrane oxygenation (<b>time</b> <b>point</b> 3). ResultsFour animals in group A did not reach <b>time</b> <b>point</b> 2; all died of pulmonary edema. All animals in group B survived, and at <b>time</b> <b>point</b> 3, the mean Pao 2 value was 323 ± 129 mm Hg. At <b>time</b> <b>point</b> 2, oxygenation and lung compliance were higher in group B than in group A, whereas pulmonary artery pressure was lower. The same was true when comparing results of group B at <b>time</b> <b>point</b> 3 with results of group A at <b>time</b> <b>point</b> 2. ConclusionsTransplantation during extracorporeal membrane oxygenation with continued use for 24 hours restores function of damaged donor lungs. This could expand the donor pool through wider use of marginal donors...|$|R
5000|$|Moving averagean average over {{a window}} of time before and after a given <b>time</b> <b>point</b> that is {{repeated}} at each <b>time</b> <b>point</b> in the given chart. A moving average {{can be thought of}} as a kind of dynamic trend-line.|$|R
40|$|The Chan, Karolyi, Longstaff and Sanders (CKLS) {{model is}} a popular one-factor model for {{describing}} the spot interest rates. In this paper, the four parameters in the CKLS model are regarded as stochastic. The parameter vector φ(j) of four parameters at the (J+n) -th <b>time</b> <b>point</b> is estimated by the j-th window which {{is defined as the}} set consisting of the observed interest rates at the j′-th <b>time</b> <b>point</b> where j≤j′≤j+n. To model the variation of φ(j), we assume that φ(j) depends on φ(j−m), φ(j−m+ 1),…, φ(j− 1) and the interest rate r j+n at the (j+n) -th <b>time</b> <b>point</b> via a four-dimensional conditional distribution which is derived from a [4 (m+ 1) + 1] -dimensional power-normal distribution. Treating the (j+n) -th <b>time</b> <b>point</b> as the present <b>time</b> <b>point,</b> we find a prediction interval for the future value r j+n+ 1 of the interest rate at the next <b>time</b> <b>point</b> when the value r j+n of the interest rate is given. From the above four-dimensional conditional distribution, we also find a prediction interval for the future interest rate r j+n+d at the next d-th (d≥ 2) <b>time</b> <b>point.</b> The prediction intervals based on the CKLS model with stochastic parameters are found to have better ability of covering the observed future interest rates when compared with those based on the model with fixed parameters...|$|R
25|$|Biopsy-free tumor genotyping, {{by way of}} CAPP-Seq and ctDNA, {{addresses}} many {{of these}} issues. A simple blood test is non-invasive and much safer and easier to subject cancer patients to multiple times {{through the course of}} treatment. Using ctDNA gives a better sample of tumor DNA compared to a single area of a tumor collected in a biopsy, allowing a better estimate of tumor heterogeneity. Taking multiple samples of ctDNA at different <b>time</b> <b>points</b> following the course of treatment allows tumor evolution to be uncovered. This can help detect the emergence of mutations that confer resistance to a targeted therapy and allow the course of treatment to be adjusted accordingly. CAPP-Seq specifically allows for the screening of multiple genomic locations which will become important as the list of cancer mutations important for treatment continues to grow. In a study for late stage NSCLC, they performed a version of CAPP-Seq where the tumor biopsy was not sequenced first, {{and they were able to}} correctly classify 100% of patient plasma samples with a 0% false positive rate. This shows that even without previous knowledge of tumor mutations, they can be accurately discovered by ctDNA alone.|$|E
500|$|Dynamic testing {{examined}} [...] "the vehicle's {{response to}} lateral, longitudinal, and torsional excitation, simulating those {{that would be}} experienced in flight. [...] The vehicle was [...] "mounted on a hydrodynamic support system made up of four hydraulic/pneumatic pedestals to permit a simulated unrestrained reaction." [...] Engineers tested vibrations in one plane at a time with different amounts of ballast simulating [...] "fuel load at critical <b>time</b> <b>points</b> in the flight trajectory." ...|$|E
500|$|He {{completed}} {{the course in}} a time of 54' 19", and his time held for around an hour before his teammate Lieuwe Westra assumed top spot; despite being ten seconds down on Larsson at the second intermediate time point, Westra {{completed the}} final portion of the course some twenty seconds quicker, and recorded a time of 54' 09". 's Tony Martin, the world champion, was the next rider to assume the top spot, setting the first time underneath 54 minutes; he set a time of 53' 40", despite riding with a fractured scaphoid bone in his left wrist and suffering a flat tyre in the opening [...] of the stage. Fabian Cancellara of [...] improved the quickest time benchmark; he set the fastest time at each of the two intermediate <b>time</b> <b>points</b> on the stage, and having passed the rider who started three minutes before him on the road, 's Bauke Mollema, Cancellara established a time for the course of 52' 21", beating Martin's time by 1' 19".|$|E
30|$|If a ship {{tries to}} join the SANET, it can {{synchronize}} the time by checking the current <b>time</b> <b>point</b> and converting the <b>time</b> <b>point</b> into EASO-TDMA <b>time</b> units which can be {{expressed in terms of}} HN, SN, MN, TN, and TSN.|$|R
30|$|For vaginal gel, insert, {{and film}} swab {{extracts}} (Table  6), excipient and FTIR data were expressed as {{the percent of}} total swabs per <b>time</b> <b>point</b> from ten women that had positive detection of the placebo product. Each woman provided one swab per <b>time</b> <b>point.</b> For IVR adherence measures (Fig.  4), twenty women used one IVR during each timeframe. Differences among mean glycerin and bioanalyte values of twenty IVR extracts per <b>time</b> <b>point</b> were compared by Repeated Measures ANOVA, significance at p[*]<[*] 0.05.|$|R
3000|$|... [33] was used. Before Logan analysis, both {{brain and}} plasma {{concentrations}} were corrected for labeled metabolites. As metabolite fractions were not measured at each plasma or mid-frame <b>time</b> <b>point,</b> linear regression {{was used to}} estimate the fraction of intact 11 C]phenytoin at each <b>time</b> <b>point.</b>|$|R
2500|$|A time {{interval}} is the intervening time between two <b>time</b> <b>points.</b> The amount of intervening time is expressed by a duration (as {{described in the}} previous section). [...] The two <b>time</b> <b>points</b> (start and end) are expressed by either a combined date and time representation or just a date representation.|$|E
2500|$|Depending {{on whether}} an assay {{just looks at}} a single time point or timed {{readings}} taken at multiple <b>time</b> <b>points,</b> an assay may be: ...|$|E
2500|$|... fMRS {{differs from}} MRS by {{acquiring}} {{not one but}} multiple spectra at different <b>time</b> <b>points</b> while the participant is inside the MRI scanner. Thus, temporal resolution is very important and acquisition times need to be kept adequately short to provide a dynamic rate of metabolite concentration change.|$|E
40|$|PURPOSE: We have {{previously}} reported on measuring macular pigment density (MPD) with a scanning laser ophthalmoscope (HRA, Heidelberg Engineering, Heidelberg, Germany). This study war undertaken {{to evaluate the}} variation of MPD {{over a period of}} 1 year in healthy subjects. METHOD: We used autofluorescence images recorded with a HRA to evaluate MPD with a 2 degrees circle centered on the fovea. Healthy subjects were included in the study and MPD measurements were repeated every 2 months over a period of 1 year. RESULTS: We included a total of 30 healthy subjects aged 19 - 34 years (mean: 23 +/- 2 years). Mean MPD at <b>time</b> <b>point</b> 1 was 0. 215 +/- 0. 056 density units (DU), at <b>time</b> <b>point</b> 2 0. 235 +/- 0. 051 DU, at <b>time</b> <b>point</b> 3 0. 218 +/- 0. 055 DU, at <b>time</b> <b>point</b> 4 0. 228 +/- 0. 057 DU, at <b>time</b> <b>point</b> 5 0. 225 +/- 0. 053 DU, and at <b>time</b> <b>point</b> 6 0. 203 +/- 0. 050 DU. The statistical analysis revealed no significant variation of MPD over the follow-up period of 1 year. CONCLUSION: This study demonstrates that MPD shows no variation over a period of 1 year in healthy subjects...|$|R
30|$|In this equation, T {{represents}} the train operating {{time in the}} network, t 1 {{represents the}} <b>time</b> <b>point</b> when an oversaturated condition begins at a station (e.g., Xizhimen Station), and t 2 represents the <b>time</b> <b>point</b> when an oversaturated condition begins at the connected station (e.g., Chegongzhuang Station).|$|R
5000|$|Position {{along the}} flowing stream and {{reaction}} <b>time</b> <b>point</b> {{are directly related}} to one another. This means {{that it is possible to}} arrange the system such that further reagents can be introduced into the flowing reaction stream at precisely the <b>time</b> <b>point</b> in the reaction that is desired.|$|R
2500|$|... "The {{goal is to}} {{reconstruct}} the history of every gene in the human genome," [...] said Evan Eichler, University of Washington, Seattle. DNA from different branches of the primate tree will allow us [...] "to trace back the evolutionary changes that occurred at various <b>time</b> <b>points,</b> leading from the common ancestors of the primate clade to Homo sapiens," [...] said Bruce Lahn, University of Chicago.|$|E
2500|$|An imaging centre that is {{responsible}} for collecting the images, perform quality control and provide tools for data storage, distribution and analysis. [...] It is important for images acquired at different <b>time</b> <b>points</b> are displayed in a standardised format to maintain the reliability of the evaluation. [...] Certain specialised imaging contract research organizations provide end to end medical imaging services, from protocol design and site management through to data quality assurance and image analysis.|$|E
2500|$|Individuals {{who have}} coeliac disease may have values {{in excess of}} 200. There is the common {{expectation}} that removal of gluten results {{in the loss of}} AGA; however, since gluten is the target of the antibodies, that which would deplete them from the body, removal of gluten results in the benign circulation of antibodies. The half life of these antibodies is typically 120 days. Given an expected normal of 3 and assuming that the individual starts with a score of 203, we can predict the levels of AGA at various future <b>time</b> <b>points.</b> Based on these initial numbers, patients with very high ...|$|E
5000|$|Northern Emberá and Katio make a clear {{distinction}} (immediate vs. unspecified temporal distance) in those tenses in which the event <b>time</b> <b>point</b> does not coincide with the speech <b>time</b> <b>point</b> (past and future)For example: Northern Emberá wã-toko-a (go-IMM_PST-DECL) ‘s/he just left’ vs. wã-podo-a (go-IMM_FUT-DECL) ‘s/he is about to leave’ ...|$|R
5000|$|Standard Univariate ANOVA F test—This test is {{commonly}} used given only two levels of the within-subjects factor (i.e. <b>time</b> <b>point</b> 1 and <b>time</b> <b>point</b> 2). This test is not recommended given more than 2 levels of the within-subjects factor because the assumption of sphericity {{is commonly}} violated in such cases.|$|R
30|$|In {{instances}} where demands on both patients and facilities make multiple <b>time</b> <b>point</b> data acquisition impractical, renal dosimetry is best derived through complete imaging at cycle 1 only {{followed by a}} single 24 [*]h imaging <b>time</b> <b>point</b> on subsequent cycles, assuming no significant changes in renal function during {{the time course of}} therapy.|$|R
